The main indications and scope of use of Brivaracetam

Brivaracetam is a new type of selective anti-epileptic drug that mainly targets focal seizures and is suitable for adults and children 1 month and above. Its core mechanism of action is to bind to synaptic vesicle protein 2A (SV2A) with high affinity, thereby regulating abnormal neuronal discharge activity and reducing the frequency of epileptic seizures. Compared with traditional anti-epileptic drugs, brivaracetam is highly targeted and can inhibit abnormal discharges while having less impact on normal neural activity. This is also its significant advantage in cognitive protection.

In clinical application, brivaracetam can be used as a single agent or in combination with other anti-epileptic drugs, especially for patients with refractory partial seizures. In adult patients, it can effectively reduce the number of attacks and improve the quality of life. At the same time, because the side effects are relatively mild, it is safe for long-term use. For children and infants, Brivaracetam also shows good tolerance, and the dosage can be individually adjusted based on weight and age to ensure both efficacy and safety.

It is worth noting that partial seizures have diverse clinical manifestations, including unilateral limb seizures, focal myoclonus, or complex focal behavioral manifestations. Brivaracetam fundamentally reduces these abnormalities in focal neural activity by regulating the synchronized firing and hyperexcitability of neurons, thereby controlling symptoms. Studies have shown that brivaracetam can significantly reduce the frequency of epileptic seizures in long-term treatment, and some patients can even achieve clinical complete remission or sustained stable control.

In addition, the pharmacokinetic properties of brivaracetam enable it to have good penetration of the blood-brain barrier, allowing it to quickly enter the central nervous system and maintain effective drug concentrations. This is particularly important for controlling complex partial seizures, improving cognitive function, and reducing sudden epileptic events.

Reference materials:https://www.briviact.com/